cilengitide has been researched along with cp-55,940 in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (cp-55,940) | Trials (cp-55,940) | Recent Studies (post-2010) (cp-55,940) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 130 | 0 | 77 |
| Protein | Taxonomy | cilengitide (IC50) | cp-55,940 (IC50) |
|---|---|---|---|
| Cytochrome P450 2C8 | Homo sapiens (human) | 0.0008 | |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.004 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 0.0042 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 0.0028 | |
| N-arachidonyl glycine receptor | Homo sapiens (human) | 5.99 | |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.0021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JG; Babij, P; Fotsch, C | 1 |
1 review(s) available for cilengitide and cp-55,940
| Article | Year |
|---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |